美國的糖尿病用注射筆的特徵:2011年

2011 U.S. Diabetes Injection Pens' Features

出版商	Frost & Sullivan
出版日期	2011年08月	商品編碼	209511
內容資訊	英文 66 Pages
價格	US $ 10000 Web Access (Regional License) US $ 10500 Hard Copy & Web Access (Regional License)

簡介
目錄
相關商品

美國的糖尿病用注射筆的特徵:2011年 是由出版商Frost & Sullivan在2011年08月所出版的。這份英文市場調查報告書包含66 Pages 價格從美金10000起跳。

簡介

本報告提供美國第二型糖尿病患者的筆型注射器使用趨勢調查分析，彙整不同品牌趨勢，注射筆的特徵及特性，不同品牌滿足度，未來使用預測等資料，為您概述為以下內容。

背景調查，調查目的，調查方法，人口統計
摘要整理
主要的注射筆品牌使用
Lantus SoloSTAR Pen詳細內容
NovoLog Flex Pen詳細內容
Byetta Pen詳細內容
Humalog KwikPen詳細內容
Humulin Pen詳細內容
NovoPen3 Pen詳細內容
NovoLog Mix Pen 詳細內容
SymlinPen 詳細內容
NovoPen3 PenMate 詳細內容
OptiClik Pen詳細內容
關於Frost＆Sullivan

A majority of type 2 diabetics currently use Lantus SoloSTAR Pen. Most of them use prefilled injection pens that are entirely disposable. These pens are more convenient to use for most patients with busy lifestyles, as they come pre-filled with insulin/medication. Easy push-button injection, transparent cartridge, and a window showing injection is complete are the features desired by all current injection pen users. The top three features for which most patients are likely to switch to another brand (if their current pen does not have those features) are easy push-buttons, pen memory, and highly automated.

Methodology:

A Web-based survey methodology was utilized. Specifically, this methodology utilizes online panels to source only qualified respondents. Respondents must meet requirements set by screening process, prior to full survey participation. Online panels consist of individuals who volunteer participate in Web-based surveys. They typically receive compensation directly from their panel membership for participating in qualified survey research. In general, survey respondents do not receive direct compensation from Frost & Sullivan for participating in our research.